Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Genistein inhibits colorectal cancer progression via regulating the LINC00355/miR-150/SGK1 axis and downstream EGFR/PI3K/AKT and MAPK signaling pathways.

This study provides reliable experimental evidence for the development of genistein as a potential adjuvant therapeutic agent for CRC treatment by revealing that genistein dose-dependently inhibited CRC cell proliferation without obvious cytotoxicity to normal colon cells.

Xing Zhou, Jian Qin, Zhong-Wen Feng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.